Beiley Biofund

Beiley Biofund Net Tangible Assets

The Net Tangible Assets of Beiley Biofund (7882.TWO) as of Nov 21, 2026 is 2.22 B TWD. In the previous year, Net Tangible Assets was 2.12 B TWD — a change of 4.55% (higher).

Net Tangible Assets

2.22 BTWD

YoY

4.55%

Last updated:

Net Tangible Assets of Beiley Biofund is 2024 2.22 B TWD. Net Tangible Assets of Beiley Biofund was 2023 2.12 B TWD. It decreases by 4.55% higher compared to the previous year.

The Beiley Biofund Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2023
2.12 B TWD
Jan 1, 2024
2.22 B TWD
The Beiley Biofund Net Tangible Assets history
YEARNet Tangible AssetsYoY
2.22 BTWD+4.55%
2.12 BTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beiley Biofund Stock analysis

What does Beiley Biofund do? Beiley Biofund Inc generates revenue through venture capital investments in biotechnology and healthcare sectors. The company focuses on new drug and pharmaceutical R&D, advanced medical devices, pharmaceutical manufacturing, diagnostics, precision medicine, innovative medical service technologies, healthcare networks, and agricultural biotechnology. Its primary investment scope is domestic, targeting companies within Taiwan's biotech industry. The firm's revenue comes from capital gains and returns on its portfolio investments in these specialized areas. Beiley Biofund Inc operates as a Taiwan-based venture capital firm with a domestic investment focus. It targets biotechnology and healthcare companies developing innovative solutions in drug development, medical devices, and precision medicine. The firm's investment strategy centers on companies within Taiwan's biotech ecosystem, providing capital for growth and innovation. Revenue is derived from successful exits and equity appreciation in its portfolio companies. The company's investment areas include pharmaceutical manufacturing and services, diagnostics, precision medicine, and agricultural biotechnology. Beiley Biofund Inc concentrates on firms within Taiwan's domestic market, making capital available for biotech startups and established players. Revenue is generated through the financial performance of its investment portfolio in these specific sectors. Beiley Biofund is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beiley Biofund stock

Net Tangible Assets of Beiley Biofund is 2.22 B TWD in 2024.

Net Tangible Assets of Beiley Biofund changed from 2.12 B TWD to 2.22 B TWD, representing a 4.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Beiley Biofund since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Beiley Biofund historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Beiley Biofund

All Key Metrics — Beiley Biofund